Designed for poorly soluble lipophilic actives.
MTRX is a proprietary solid-state delivery technology platform for transforming challenging lipophilic botanical actives, cannabinoids and partner-selected molecules into advanced oral and topical candidate formats.
Solid-state self-emulsifying architecture.
The platform is intended to improve formulation viability, support differentiated delivery design and create a more robust development bridge for lipophilic actives that are difficult to translate using conventional formats.
Composition
Matrix and amphiphile architecture designed to support solid-state delivery system generation.
Process
Proprietary conversion methodology transforms lipophilic inputs into stable, usable powder formats.
Performance
Candidate systems can be evaluated through dispersion, solubility, stability and PK-oriented screening.
Technical integration pathway.
Compound selection
Identify lipophilic actives that fit the MTRX platform and partner objectives.
Feasibility formulation
Generate prototype solid-state systems for oral or topical route evaluation.
Performance screening
Screen dispersion, physical behavior, stability and formulation relevance.
Development package
Define next-step PK, regulatory, scale-up or clinical-test-article pathways.